Guardant Health Inc (1GH)

Currency in EUR
38.98
-0.75(-1.89%)
Closed·
1GH Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
1GH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
38.9838.98
52 wk Range
33.0144.45
Key Statistics
Prev. Close
38.98
Open
38.98
Day's Range
38.98-38.98
52 wk Range
33.01-44.45
Volume
-
Average Volume (3m)
32
1-Year Change
-
Book Value / Share
-1.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1GH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Guardant Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Guardant Health Inc Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Industry
-
Sector
-
Employees
2010
Market
Italy

Compare 1GH to Peers and Sector

Metrics to compare
1GH
Peers
Sector
Relationship
P/E Ratio
−13.6x−1.3x−0.5x
PEG Ratio
−0.94−0.090.00
Price/Book
−22.5x1.8x2.6x
Price / LTM Sales
7.3x1.1x3.2x
Upside (Analyst Target)
-66.5%42.7%
Fair Value Upside
Unlock20.8%5.8%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-0.77 / --
Revenue / Forecast
203.47M / --
EPS Revisions
Last 90 days

1GH Income Statement

People Also Watch

262.48
AVAV
-3.56%
23.51
VCYT
+2.08%
44.440
SMR
-2.20%
60.08
MP
+1.81%

FAQ

What Stock Exchange Does Guardant Health Inc Trade On?

Guardant Health Inc is listed and trades on the Milan Stock Exchange stock exchange.

What Is the Stock Symbol for Guardant Health Inc?

The stock symbol for Guardant Health Inc is "1GH."

What Is the Guardant Health Inc Market Cap?

As of today, Guardant Health Inc market cap is 4.88B.

What Is Guardant Health Inc's Earnings Per Share (TTM)?

The Guardant Health Inc EPS (TTM) is -3.38.

From a Technical Analysis Perspective, Is 1GH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Guardant Health Inc Stock Split?

Guardant Health Inc has split 0 times.

How Many Employees Does Guardant Health Inc Have?

Guardant Health Inc has 2010 employees.

What is the current trading status of Guardant Health Inc (1GH)?

As of 23 Jul 2025, Guardant Health Inc (1GH) is trading at a price of 38.98, with a previous close of 38.98. The stock has fluctuated within a day range of 38.98 to 38.98, while its 52-week range spans from 33.01 to 44.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.